Asprodental

Asprodental

Early Stage

Dental practice management software that is more efficient and intuitive than anything else the industry has seen.

Dental practice management software that is more efficient and intuitive than anything else the industry has seen.

Overview

Raised this Round: Raised: $27,112

Total Commitments ($USD)

Platform

Netcapital

Start Date

06/06/2019

Close Date

12/03/2019

Min. Goal
$10,000
Max. Goal
$253,000
Min. Investment

$99

Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.46

Pre-Money Valuation

$4,347,000

Year Founded

2019

Industry

Business Services, Software, & Applications

Tech Sector

Location

Fullerton, California

Asprodental, a dental practice management software with a post-money valuation of $4.3 million, is raising funds on NetCapital. The software is an enterprise SaaS for dentists that offers the management of health records, insurance billing, etc. on one platform. Asprodental also provides consumer interface and eliminates an hour of redundant paperwork per dental workday. The company was founded by Tiffany Nguyen and Kimberly Nguyen in 2018 and is growing well. The proceeds of the current crowdfunding round, with a minimum goal of $10,000 and a maximum goal of $253,000, will be used for feature enhancements, marketing, support and maintenance, and data conversion. Asprodental already has two revenue generating clients and is ready to onboard a third client.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Analyst Report Analyst Report Methodology Article

Summary

Asprodental has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected into the top 10%-20% of our due diligence funnel. If you have questions regarding our deal diligence and selection methodology, please reach out to hello@kingscrowd.com. 

Next Section: Problem

Problem

The healthcare industry has lately been heavily scrutinized as the demand to lower the cost of healthcare clashes with the demand for increased quality. In recent years, private practices struggled to keep up with the rate at which large corporations have managed to lower their prices, despite corporations offering insuperior( inferior) care. 

This is due, in part, to outdated technologies and systems that have kept owners from being competitive due to their inefficiencies. Law and healthcare reform has changed the way in which private practices function, while their computing programs have not. 

While nationwide dental offices switch to cloud computing, small practices lack the ability to match their efficiency. As a result, private practices charge more while taking longer to conduct exams. This combination has allowed franchised practices to overwhelm the private sector, resulting in a 50% decrease in the number of practices in recent years. 

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Asprodental on NetCapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $4,347,000
Price per Share: $0.46

Follow company

Follow Asprodental on NetCapital

Buy Asprodental's Deal Report

Warning: according to the close date for this deal, Asprodental may no longer be accepting investments.

Asprodental Deal Report

Get KingsCrowd’s comprehensive report on Asprodental including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Asprodental is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the Asprodental deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge